Search

Using Multiple Technologies to Maximize Quality of Vision

I. Paul Singh, MD

Show Description +

In the age of interventional glaucoma, surgeons often must utilize multiple technologies to help reduce the glaucoma medication burden and maximize quality of vision. In this case, I. Paul Singh, MD, uses the Hydrus Microstent (Alcon), iDose TR (Glaukos), an enVista Aspire Toric IOL (Bausch + Lomb), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Financial Disclosures: Consultant (Alcon, Bausch + Lomb, Glaukos)

Posted: 10/27/2025

Keywords:

Hydrus Microstent (Alcon)

•

iDose TR

Up Next

Management of Dislocated Posterior Chamber IOL

Management of Dislocated Posterior Chamber IOL

Altan A. Ozcan, MD

Posterior Lamellar Keratoplasty and Dislocated IOL

Posterior Lamellar Keratoplasty and Dislocated IOL

Ozana Moraru, MD

Scleral Fixation of Dislocated IOL Complex

Scleral Fixation of Dislocated IOL Complex

Majid Moshirfar, MD

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

Michael Patterson, DO

Refixation of a Dislocated Gortex Sutured Akreos IOL

Refixation of a Dislocated Gortex Sutured Akreos IOL

Jason N. Crosson, MD, Michael A. Albert MD

Dislocated IOL to Glued IOL

Dislocated IOL to Glued IOL

Michael Patterson, DO

Bubble Bubble Toil and Trouble

Bubble Bubble Toil and Trouble

Jason Jones, MD

Phacoemulsification Hard Cataract With Lens Coloboma

Phacoemulsification Hard Cataract With Lens Coloboma

Maneesh Bapaye, MD

Phaco Debulk Chop for Dense Cataracts

Phaco Debulk Chop for Dense Cataracts

Iqbal "Ike" K. Ahmed, MD, FRCSC

My Technique for Modern ECCE

My Technique for Modern ECCE

Ashraf Armia, MD

Using Multiple Technologies to Maximize Quality of Vision

I. Paul Singh, MD

In the age of interventional glaucoma, surgeons often must utilize multiple technologies to help reduce the glaucoma medication burden and maximize quality of vision. In this case, I. Paul Singh, MD, uses the Hydrus Microstent (Alcon), iDose TR (Glaukos), an enVista Aspire Toric IOL (Bausch + Lomb), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Financial Disclosures: Consultant (Alcon, Bausch + Lomb, Glaukos)

Posted: 10/27/2025

Keywords:

Hydrus Microstent (Alcon)

•

iDose TR

Please log in to leave a comment.

More in Glaucoma

Technique for Implantation of ClearPath 250 ST

Technique for Implantation of ClearPath 250 ST

Arkadiy Yadgarov, MD

Trabeculectomy Pearls From the Moran Eye Center

Trabeculectomy Pearls From the Moran Eye Center

Rachel G. Simpson, MD; and Roya Garakani, DO

Redefining Success in the Era of Interventional Glaucoma

Redefining Success in the Era of Interventional Glaucoma

I. Paul Singh, MD; and Christine M. Funke, MD

Innovations in Glaucoma Surgery: A Protocol for Integrating Interventional Principles

Innovations in Glaucoma Surgery: A Protocol for Integrating Interventional Principles

I. Paul Singh, MD; and Christine M. Funke, MD